Details for Patent: 5,604,213

✉ Email this page to a colleague

Summary for Patent: 5,604,213

Patent landscape, scope, and claims:

Title:	17-substituted steroids useful in cancer treatment
Abstract:	Compounds of the general formula (1) ##STR1## wherein X represents the residue of the A, B and C rings of a steroid, R represents a hydrogen atom or an alkyl group of 1 to 4 carbon atoms, R.sup.14 represents a hydrogen atom and R.sup.15 represents a hydrogen atom or an alkyl or alkoxy group of 1-4 carbon atoms, or a hydroxy or alkylcarbonyloxy group of 2 to 5 carbon atoms or R.sup.14 and R.sup.15 together represent a double bond, and R.sup.16 represents a hydrogen atom or an alkyl group of 1 to 4 carbon atoms, in the form of the free bases or phannaceutically acceptable acid addition salts, are useful for treatment of androgen-dependent disorders, especially prostatic cancer, and also oestrogen-dependent disorders such as breast cancer.
Inventor(s):	Barrie; Susan E. (Kent, GB3), Jarman; Michael (London, GB3), Potter; Gerard A. (Cheshire, GB3), Hardcastle; Ian R. (Sutton, GB3)
Assignee:	British Technology Group Limited (London, GB2)
Application Number:	08/315,882
Patent Claim Types: see list of patent claims	Compound; Use; Composition;
More… ↓ ⤷ Subscribe

Drugs Protected by US Patent 5,604,213

Glossary

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

Foreign Priority and PCT Information for Patent: 5,604,213

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
United Kingdom	9207057	Mar 31, 1992
United Kingdom	9224880	Nov 27, 1992
United Kingdom	9320132	Sep 30, 1993
United Kingdom	9414192	Jul 14, 1994

International Family Members for US Patent 5,604,213

Subscribe to access the full database, or Subscribe
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
European Patent Office	0633893	⤷ Subscribe	C300508	Netherlands	⤷ Subscribe
European Patent Office	0633893	⤷ Subscribe	CA 2011 00035	Denmark	⤷ Subscribe
European Patent Office	0633893	⤷ Subscribe	91911	Luxembourg	⤷ Subscribe
European Patent Office	0633893	⤷ Subscribe	1190040-4	Sweden	⤷ Subscribe
European Patent Office	0633893	⤷ Subscribe	C00633893/01	Switzerland	⤷ Subscribe
European Patent Office	0633893	⤷ Subscribe	11C0055	France	⤷ Subscribe
European Patent Office	0633893	⤷ Subscribe	SPC/GB11/063	United Kingdom	⤷ Subscribe
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.